These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Prevalence of pathogenic germline variants in patients with metastatic renal cell carcinoma. Santos M; Lanillos J; Roldan-Romero JM; Caleiras E; Montero-Conde C; Cascón A; Climent MA; Anguera G; Hernando S; Laínez N; Robledo M; Robles L; de Velasco G; García-Donas J; Rodriguez-Antona C Genet Med; 2021 Apr; 23(4):698-704. PubMed ID: 33442023 [TBL] [Abstract][Full Text] [Related]
12. Double Hit in Clear-Cell Renal Cell Carcinoma With Germline Pathogenic ATM Mutation and Somatic VHL Mutation. Chan KH; Clavijo ND; Ayala G; Hall R; Wray C; Cen P J Investig Med High Impact Case Rep; 2024; 12():23247096241286370. PubMed ID: 39369320 [TBL] [Abstract][Full Text] [Related]
13. Genetic kidney cancer syndromes. Ho TH; Jonasch E J Natl Compr Canc Netw; 2014 Sep; 12(9):1347-55. PubMed ID: 25190700 [TBL] [Abstract][Full Text] [Related]
14. Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing. Mandelker D; Zhang L; Kemel Y; Stadler ZK; Joseph V; Zehir A; Pradhan N; Arnold A; Walsh MF; Li Y; Balakrishnan AR; Syed A; Prasad M; Nafa K; Carlo MI; Cadoo KA; Sheehan M; Fleischut MH; Salo-Mullen E; Trottier M; Lipkin SM; Lincoln A; Mukherjee S; Ravichandran V; Cambria R; Galle J; Abida W; Arcila ME; Benayed R; Shah R; Yu K; Bajorin DF; Coleman JA; Leach SD; Lowery MA; Garcia-Aguilar J; Kantoff PW; Sawyers CL; Dickler MN; Saltz L; Motzer RJ; O'Reilly EM; Scher HI; Baselga J; Klimstra DS; Solit DB; Hyman DM; Berger MF; Ladanyi M; Robson ME; Offit K JAMA; 2017 Sep; 318(9):825-835. PubMed ID: 28873162 [TBL] [Abstract][Full Text] [Related]
16. Integrative Analysis of Germline Rare Variants in Clear and Non-clear Cell Renal Cell Carcinoma. Han SH; Camp SY; Chu H; Collins R; Gillani R; Park J; Bakouny Z; Ricker CA; Reardon B; Moore N; Kofman E; Labaki C; Braun D; Choueiri TK; AlDubayan SH; Van Allen EM Eur Urol Open Sci; 2024 Apr; 62():107-122. PubMed ID: 38496821 [TBL] [Abstract][Full Text] [Related]
17. Germline mutations of renal cancer predisposition genes and clinical relevance in Chinese patients with sporadic, early-onset disease. Wu J; Wang H; Ricketts CJ; Yang Y; Merino MJ; Zhang H; Shi G; Gan H; Linehan WM; Zhu Y; Ye D Cancer; 2019 Apr; 125(7):1060-1069. PubMed ID: 30548481 [TBL] [Abstract][Full Text] [Related]
18. Pathogenic germline variants in patients with features of hereditary renal cell carcinoma: Evidence for further locus heterogeneity. Smith PS; West H; Whitworth J; Castle B; Sansbury FH; Warren AY; Woodward ER; Tischkowitz M; Maher ER Genes Chromosomes Cancer; 2021 Jan; 60(1):5-16. PubMed ID: 32830346 [TBL] [Abstract][Full Text] [Related]
19. Biallelic inactivation of the SDHC gene in renal carcinoma associated with paraganglioma syndrome type 3. Malinoc A; Sullivan M; Wiech T; Schmid KW; Jilg C; Straeter J; Deger S; Hoffmann MM; Bosse A; Rasp G; Eng C; Neumann HP Endocr Relat Cancer; 2012 Jun; 19(3):283-90. PubMed ID: 22351710 [TBL] [Abstract][Full Text] [Related]
20. Comprehensive Molecular Characterization and Response to Therapy in Fumarate Hydratase-Deficient Renal Cell Carcinoma. Gleeson JP; Nikolovski I; Dinatale R; Zucker M; Knezevic A; Patil S; Ged Y; Kotecha RR; Shapnik N; Murray S; Russo P; Coleman J; Lee CH; Stadler ZK; Hakimi AA; Feldman DR; Motzer RJ; Reznik E; Voss MH; Chen YB; Carlo MI Clin Cancer Res; 2021 May; 27(10):2910-2919. PubMed ID: 33658299 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]